From: Adaptation and validation of the patient assessment of chronic illness care in the French context
Study | Country | Sample size | Chronic condition(s)* | Factor analysis | Gender (% male) | Age (mean + SD or %) | PACIC mean score (SD) |
---|---|---|---|---|---|---|---|
Maindal et al. [37] | Denmark | 481 | DM | Confirmatory | 60% | 66,4 (10,7) | 2,83 (-) |
Rosemann et al. [25] | Germany | 236 | OA | Exploratory | 45% | - | 2,44 (1,1) |
Schmittdiel et al. [46] | USA | 4,108 | RESP; DM; HF; CAD; Pain | No | 50% | 61,9 (14,7) | 2,7 (1,1) |
Vrijhoef et al. [44] | Netherlands | 89 | COPD; HF; Arthritis; Geriatric disorders | No | 49% | 56% " > 65 years" | 2,6 (-) |
Taggart et al. [42] | Australia | 2,438 | DM; IHD | Exploratory | 47% | 63,2 (-) | 3,01 (1,07) |
Taggart et al. [42] | Australia | 914 | DM; IHD | Exploratory | 43% | 57,4% " ≥ 60 years" | 3,07 (1,06) |
Aragones et al. [27] | USA (Spanish language) | 100 | DM | Confirmatory | 21% | - | 3,17 (0,82) |
Wensing et al. [41] | Netherlands | 165 | DM; COPD | Exploratory | 53% | 68 (10,3) | 2,9 (1) |
Rick et al. [39] | UK | 2,439 | Various | Confirmatory | 51% | 51,7% " ≥ 65 years" | 2,4 (0,87) |
Ludt et al. [47] | Europe | 1,745 | CVD | No | 68% | 67,8 (9,9) | 2,84 (-) |
Szecsenyi et al. [45] | Germany | 1,399 | DM | No | 46% | 70,3 (8,5) | 2,86 to 3,21 Glasgow |
Glasgow et al. [24] | USA | 266 | Various | Confirmatory | 44% | 64,2 (10,5) | 2,6 (1) |
Mackey et al. [26] | USA | 1,823 | DM | No | 35% | 51,5 (16,7) | 3,05 (1,19) |
Glasgow et al. [17] | USA | 363 | DM | No | 53% | 64,1 (11,9) | 3,2 (0,9) |
Cramm & Nieboer [38] | Netherlands | 1,321 | CVD | Confirmatory | 53% | 63,8 (10,2) | 2,68 (0,86) |
Cramm & Nieboer [38] | Netherlands | 917 | COPD | No | 52% | 63,99 (10,19) | 2,89 (0,89) |
Cramm & Nieboer [48] | Netherlands | 1,570 | CVD | No | 53% | 66,11 (10,57) | 2,77 (0,86) |
Cramm & Nieboer [50] | Netherlands | 892 | COPD | No | 54% | 66.1 (10.6) | 2.89 (0.9) |
Cramm & Nieboer [49] | Netherlands | 283 | Older people (>65Â years) | Confirmatory | 46% | 75.8 (6.8) | - |
Cramm & Nieboer [51] | Netherlands | 548 | COPD | No | 54% | 69.1 (10.2) | 2.85 (0.92) |
USA | 529 | DM | Confirmatory/ Exploratory | 52.70% | 63,4 (-) | - | |
Spicer et al. [18] | New Zealand | 307 | DM; CDV; RESP; Pain | - | 56% | 68,4 (-) | - |
McIntosh [40] | Canada | 936 | - | Confirmatory | - | _ | - |